Free Trial
NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Price, News & Analysis

Creative Medical Technology logo
$2.64 -0.27 (-9.28%)
Closing price 04:00 PM Eastern
Extended Trading
$2.78 +0.14 (+5.11%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Creative Medical Technology Stock (NASDAQ:CELZ)

Key Stats

Today's Range
$2.59
$2.86
50-Day Range
$1.93
$3.94
52-Week Range
$1.69
$6.90
Volume
115,878 shs
Average Volume
112,464 shs
Market Capitalization
$6.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creative Medical Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

CELZ MarketRank™: 

Creative Medical Technology scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Creative Medical Technology.

  • Earnings Growth

    Earnings for Creative Medical Technology are expected to grow in the coming year, from ($3.19) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Creative Medical Technology is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Creative Medical Technology is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Creative Medical Technology has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Creative Medical Technology's valuation and earnings.
  • Percentage of Shares Shorted

    2.41% of the float of Creative Medical Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Creative Medical Technology has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Creative Medical Technology has recently increased by 53.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Creative Medical Technology does not currently pay a dividend.

  • Dividend Growth

    Creative Medical Technology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.41% of the float of Creative Medical Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Creative Medical Technology has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Creative Medical Technology has recently increased by 53.79%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Creative Medical Technology has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Creative Medical Technology this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Creative Medical Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.80% of the stock of Creative Medical Technology is held by insiders.

  • Percentage Held by Institutions

    Only 1.42% of the stock of Creative Medical Technology is held by institutions.

  • Read more about Creative Medical Technology's insider trading history.
Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

CELZ Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

CELZ Stock Analysis - Frequently Asked Questions

Creative Medical Technology's stock was trading at $2.31 at the beginning of 2025. Since then, CELZ shares have increased by 14.3% and is now trading at $2.64.

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its earnings results on Friday, May, 9th. The company reported ($0.83) earnings per share for the quarter, missing analysts' consensus estimates of ($0.52) by $0.31. The company had revenue of $0 million for the quarter.

Creative Medical Technology shares reverse split on Sunday, June 11th 2023.The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creative Medical Technology investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL) and ChargePoint (CHPT).

Company Calendar

Last Earnings
5/09/2025
Today
7/14/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELZ
CIK
1187953
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.49 million
Net Margins
N/A
Pretax Margin
-43,492.86%
Return on Equity
-85.26%
Return on Assets
-81.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
27.43
Quick Ratio
27.42

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
753.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.63 per share
Price / Book
0.80

Miscellaneous

Outstanding Shares
2,590,000
Free Float
2,539,000
Market Cap
$7.54 million
Optionable
Not Optionable
Beta
2.04
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CELZ) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners